Emerging Applications of Artificial Intelligence in Neuro-Oncology
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Due to the exponential growth of computational algorithms, artificial intelligence (AI) methods are poised to improve the precision of diagnostic and therapeutic methods in medicine. The field of radiomics in neuro-oncology has been and will likely continue to be at the forefront of this revolution. A variety of AI methods applied to conventional and advanced neuro-oncology MRI data can already delineate infiltrating margins of diffuse gliomas, differentiate pseudoprogression from true progression, and predict recurrence and survival better than methods used in daily clinical practice. Radiogenomics will also advance our understanding of cancer biology, allowing noninvasive sampling of the molecular environment with high spatial resolution and providing a systems-level understanding of underlying heterogeneous cellular and molecular processes. By providing in vivo markers of spatial and molecular heterogeneity, these AI-based radiomic and radiogenomic tools have the potential to stratify patients into more precise initial diagnostic and therapeutic pathways and enable better dynamic treatment monitoring in this era of personalized medicine. Although substantial challenges remain, radiologic practice is set to change considerably as AI technology is further developed and validated for clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
ImageNet: A large-scale hierarchical image database
Deng, J., Dong, W., Socher, R., Li, L.-J., Li, K., & Fei-Fei, L. (2009) · 2009 IEEE Conference on Computer Vision and Pattern Recognition · doi:10.1109/cvpr.2009.5206848 · Cited by 65,333
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Visualizing and understanding convolutional networks
Zeiler, M. D., & Fergus, R. (2014) · Lecture Notes in Computer Science · doi:10.1007/978-3-319-10590-1_53 · Cited by 15,839
Radiomics: Images Are More than Pictures, They Are Data
Gillies, R. J., Kinahan, P. E., & Hricak, H. (2016) · Radiology · doi:10.1148/radiol.2015151169 · Cited by 8,421
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575 · cited 1×
“gov/) identified prognostically influential gene expression–based subgroups, namely proneural, neural, classic, and mesenchymal, representing distinct cellular pathways with prognostic and therapeutic implications (28).”
BackgroundThe multimodal brain tumor image segmentation benchmark (BRATS)
Menze, B. H., Jakab, A., Bauer, S., Kalpathy-Cramer, J., Farahani, K., Kirby, J., Burren, Y., Porz, N., Slotboom, J., Wiest, R., et al. (2015) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2014.2377694 · Cited by 6,781
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
A New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository
Clark, K., Vendt, B., Smith, K., Freymann, J., Kirby, J., Koppel, P., Moore, S., Phillips, S., Maffitt, D., Pringle, M., et al. (2013) · Journal of Digital Imaging · doi:10.1007/s10278-013-9622-7 · Cited by 4,599 · cited 6×
“Since 2012, TCIA data have been further curated through the annual Multimodal Brain Tumor Image Segmentation Benchmark (BraTS) challenge (16,17), which seeks to improve the accuracy of automated glioma segmentation and survival prediction with preoperative MR images.”
MethodInfluentialThe Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods
Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G., Harvey, D., Borowski, B., Britson, P. J., L. Whitwell, J., Ward, C., et al. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21049 · Cited by 4,347
Bakas, S., Akbari, H., Sotiras, A., Bilello, M., Rozycki, M., Kirby, J. S., Freymann, J. B., Farahani, K., & Davatzikos, C. (2017) · Scientific Data · doi:10.1038/sdata.2017.117 · Cited by 3,049
Self-citationDi Martino, A., Yan, C.-G., Li, Q., Denio, E., Castellanos, F. X., Alaerts, K., Anderson, J. S., Assaf, M., Bookheimer, S. Y., Dapretto, M., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.78 · Cited by 2,780
Self-citationStupp, R., Taillibert, S., Kanner, A., Read, W., Steinberg, D. M., Lhermitte, B., Toms, S., Idbaih, A., Ahluwalia, M. S., Fink, K., et al. (2017) · JAMA · doi:10.1001/jama.2017.18718 · Cited by 2,644
Response criteria for phase II studies of supratentorial malignant glioma.
Macdonald, D. R., Cascino, T. L., Schold, S. C., & Cairncross, J. G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1277 · Cited by 2,409 · cited 1×
“Initial guidelines for response assessment followed the Macdonald criteria (74), which incorporated only the size of enhancing components.”
MethodNeuroscience-Inspired Artificial Intelligence
Hassabis, D., Kumaran, D., Summerfield, C., & Botvinick, M. (2017) · Neuron · doi:10.1016/j.neuron.2017.06.011 · Cited by 1,557
Deep learning for brain MRI segmentation: state of the art and future directions
Akkus, Z., Galimzianova, A., Hoogi, A., Rubin, D. L., & Erickson, B. J. (2017) · Journal of Digital Imaging · doi:10.1007/s10278-017-9983-4 · Cited by 1,129
Deep Learning: A Primer for Radiologists
Chartrand, G., Cheng, P. M., Vorontsov, E., Drozdzal, M., Turcotte, S., Pal, C. J., Kadoury, S., & Tang, A. (2017) · RadioGraphics · doi:10.1148/rg.2017170077 · Cited by 1,115
Current Applications and Future Impact of Machine Learning in Radiology
Choy, G., Khalilzadeh, O., Michalski, M., Do, S., Samir, A. E., Pianykh, O. S., Geis, J. R., Pandharipande, P. V., Brink, J. A., & Dreyer, K. J. (2018) · Radiology · doi:10.1148/radiol.2018171820 · Cited by 800 · cited 1×
“Major challenges to the promises of AI in radiology include high-quality ground truth data, generalizable and interpretable methods, and user-centric workflow integration (101).”
BackgroundIDH1 and IDH2 mutations in gliomas
Cohen, A. L., Holmen, S. L., & Colman, H. (2013) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-013-0345-4 · Cited by 629 · cited 1×
“Mutations in IDH1 and IDH2 are found in 70%–80% of lower-grade gliomas but only 5%– 10% of glioblastomas, which are usually secondary glioblastomas, arising from lower-grade gliomas (27,31–32).”
BackgroundMeasurement error and the replication crisis
Loken, E., & Gelman, A. (2017) · Science · doi:10.1126/science.aal3618 · Cited by 628 · cited 1×
“Unfortunately, studies with relatively small sample sizes are prone to measurement error (103).”
BackgroundIdentification of noninvasive imaging surrogates for brain tumor gene-expression modules
Diehn, M., Nardini, C., Wang, D. S., McGovern, S., Jayaraman, M., Liang, Y., Aldape, K., Cha, S., & Kuo, M. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801279105 · Cited by 440
Andronesi, O. C., Kim, G. S., Gerstner, E., Batchelor, T., Tzika, A. A., Fantin, V. R., Vander Heiden, M. G., & Sorensen, A. G. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3002693 · Cited by 438
Deep learning for segmentation of brain tumors: Impact of cross‐institutional training and testing
AlBadawy, E. A., Saha, A., & Mazurowski, M. A. (2018) · Medical Physics · doi:10.1002/mp.12752 · Cited by 208
Davatzikos, C., Rathore, S., Bakas, S., Pati, S., Bergman, M., Kalarot, R., Sridharan, P., Gastounioti, A., Jahani, N., Cohen, E., et al. (2018) · Journal of Medical Imaging · doi:10.1117/1.jmi.5.1.011018 · Cited by 204 · cited 1×
“…tools that may facilitate sharing of different methods are Modelhub (http://modelhub.ai/), Pyradiomics (http:// www.Radiomics.io/) ( 108), and the Cancer Imaging Phenomics Toolkit (https:// med.upenn.edu/cbica/captk/), which was developed to facilitate clinical translation of these tools (109,110).”
MethodSelf-citationWhen Machines Think: Radiology’s Next Frontier
Dreyer, K. J., & Geis, J. R. (2017) · Radiology · doi:10.1148/radiol.2017171183 · Cited by 183 · cited 1×
“Until AI methods are completely integrated into daily practice, it will be the role of the “centaur” radiologist (112), formed as a synergy of humans and computers, to integrate information from images, AI tools, and health records to improve the precision of radiology and health care.”
Ellingson, B. M. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0506-0 · Cited by 132 · cited 1×
“Further advancing our understanding of neuro-oncology is the nascent field of radiogenomics (imaging genomics), which correlates imaging characteristics with genetic, mutational, and expression patterns (29,30).”
BackgroundRathore, S., Bakas, S., Pati, S., Akbari, H., Kalarot, R., Sridharan, P., Rozycki, M., Bergman, M., Tunc, B., Verma, R., et al. (2018) · Lecture Notes in Computer Science · doi:10.1007/978-3-319-75238-9_12 · Cited by 57 · cited 1×
“…tools that may facilitate sharing of different methods are Modelhub (http://modelhub.ai/), Pyradiomics (http:// www.Radiomics.io/) ( 108), and the Cancer Imaging Phenomics Toolkit (https:// med.upenn.edu/cbica/captk/), which was developed to facilitate clinical translation of these tools (109,110).”
MethodSelf-citation
Cited by
Economics of artificial intelligence in healthcare: Diagnosis vs. treatment
Khanna, N. N., Maindarkar, M. A., Viswanathan, V., Fernandes, J. F. E., Paul, S., Bhagawati, M., Ahluwalia, P., Ruzsa, Z., Sharma, A., Kolluri, R., et al. (2022) · Healthcare · doi:10.3390/healthcare10122493 · Cited by 347
“This results in a reduction in the total amount of time spent performing tasks that are repetitive and laborious, while simultaneously boosting both efficiency and productivity [145,146].”
BackgroundQuanyang, W., Yao, H., Sicong, W., Linlin, Q., Zewei, Z., Donghui, H., Hongjia, L., & Shijun, Z. (2024) · Cancer Medicine · doi:10.1002/cam4.7140 · Cited by 111
Artificial intelligence in glioma imaging: Challenges and advances
Jin, W., Fatehi, M., Abhishek, K., Mallya, M., Toyota, B., & Hamarneh, G. (2020) · Journal of Neural Engineering · doi:10.1088/1741-2552/ab8131 · Cited by 55
“[21] Rudie J D, Rauschecker A M, Nick Bryan R, Davatzikos C”
Background
Metadata
- Authors
- Rudie, J. D., Rauschecker, A. M., Bryan, R. N., Davatzikos, C., & Mohan, S.
- Venue
- Radiology
- Published
- 2019-03
- Volume
- 290
- Issue
- 3
- Pages
- 607-618
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2912704013
- Cited by
- 242
- References
- 28
- FWCI
- 16.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.